Showing 61 - 80 results of 754 for search '"fibril"', query time: 0.05s Refine Results
  1. 61

    Tailoring the Ablative Strategy for Atrial Fibrillation: A State-of-the-Art Review by Zefferino Palamà, Martina Nesti, Antonio Gianluca Robles, Antonio Scarà, Silvio Romano, Elena Cavarretta, Maria Penco, Pietro Delise, Mariano Rillo, Leonardo Calò, Luigi Sciarra

    Published 2022-01-01
    “…In spite of technological progress and the improving skills of operators, atrial fibrillation (AF) ablation results appear to date to be at a plateau. …”
    Get full text
    Article
  2. 62

    Non-Pharmacological Therapy for Atrial Fibrillation: Managing the Left Atrial Appendage by Sushil Allen Luis, Damian Roper, Alexander Incani, Karl Poon, Haris Haqqani, Darren L. Walters

    Published 2012-01-01
    “…The prevalence of atrial fibrillation (AF) is increasing in parallel with an ageing population leading to increased morbidity and mortality. …”
    Get full text
    Article
  3. 63
  4. 64
  5. 65

    Patients’ Experiences of Living with Atrial Fibrillation: A Mixed Methods Study by Marie Stridsman, Anna Strömberg, Jeroen Hendriks, Ulla Walfridsson

    Published 2019-01-01
    “…Awareness of epidemiological and clinical consequences of atrial fibrillation (AF) has increased, as have disease-related costs. …”
    Get full text
    Article
  6. 66

    “Wait and See” Approach to the Emergency Department Cardioversion of Acute Atrial Fibrillation by Brian Doyle, Mark Reeves

    Published 2011-01-01
    “…Objective. Acute atrial fibrillation often spontaneously resolves. This study aimed to investigate the outcomes and satisfaction of an evidence-based ED protocol employing a “wait and see” approach. …”
    Get full text
    Article
  7. 67

    Molecular Signatures of Human Chronic Atrial Fibrillation in Primary Mitral Regurgitation by Günseli Çubukçuoğlu Deniz, Serkan Durdu, Yeşim Doğan, Esra Erdemli, Hilal Özdağ, Ahmet Ruchan Akar

    Published 2021-01-01
    “…Transcriptomics of atrial fibrillation (AFib) in the setting of chronic primary mitral regurgitation (MR) remains to be characterized. …”
    Get full text
    Article
  8. 68

    Atrial Fibrillation Caused by Intractable Hiccups: A Unique Cause and Cure by Joshua H. Arnold, Neil Brandon

    Published 2022-01-01
    “…We present the case of a 61-year-old male who developed persistent hiccups concurrently with the onset of atrial fibrillation (AF). The hiccups were refractory to traditional treatment but resolved immediately upon electrical cardioversion (ECV) to normal sinus rhythm (NSR). …”
    Get full text
    Article
  9. 69

    AI prediction model for endovascular treatment of vertebrobasilar occlusion with atrial fibrillation by Zhi-Xin Huang, Andrea M. Alexandre, Alessandro Pedicelli, Xuying He, Quanlong Hong, Yongkun Li, Ping Chen, Qiankun Cai, Aldobrando Broccolini, Luca Scarcia, Serena Abruzzese, Carlo Cirelli, Mauro Bergui, Andrea Romi, Erwah Kalsoum, Giulia Frauenfelder, Grzegorz Meder, Simona Scalise, Maria Porzia Ganimede, Luigi Bellini, Bruno Del Sette, Francesco Arba, Susanna Sammali, Andrea Salcuni, Sergio Lucio Vinci, Giacomo Cester, Luisa Roveri, Xianjun Huang, Wen Sun

    Published 2025-02-01
    “…Abstract Endovascular treatment (EVT) for vertebrobasilar artery occlusion (VBAO) with atrial fibrillation presents complex clinical challenges. This comprehensive multicenter study of 525 patients across 15 Chinese provinces investigated nuanced predictors beyond conventional metrics. …”
    Get full text
    Article
  10. 70
  11. 71
  12. 72

    Meta-Analysis of Atrial Fibrillation Ablation in Patients with Systolic Heart Failure by Mohammed Ruzieh, Andrew J. Foy, Nader M. Aboujamous, Morgan K. Moroi, Gerald V. Naccarelli, Mehrdad Ghahramani, Shaffi Kanjwal, Joseph E. Marine, Khalil Kanjwal

    Published 2019-01-01
    “…Atrial fibrillation (AF) and heart failure (HF) are two common conditions that often coexist and predispose each to one another. …”
    Get full text
    Article
  13. 73

    Cost-effectiveness of Apixaban for Stroke Prevention in Patients with Atrial Fibrillation in Algeria by Yazid Aoudia, Thitima Kongnakorn, Evie Merinopoulou, Mohamed Said Bettayeb, Sid Ahmed Kherraf

    Published 2017-05-01
    “…**Background:** Atrial fibrillation (AF) is a chronic sustained heart rhythm disorder associated with an increased risk of stroke. …”
    Get full text
    Article
  14. 74

    Preparation and Application of Cationic Modified Cellulose Fibrils as a Papermaking Additive by Yanhong Gao, Qun Li, Yu Shi, Ruitao Cha

    Published 2016-01-01
    “…This paper deals with cationic modified cellulose fibrils obtained by reacting the cellulose fibrils with 2,3-epoxypropyltrimethylammonium chloride (EPTMAC). …”
    Get full text
    Article
  15. 75

    Temperature-Responsive Gelation of Type I Collagen Solutions Involving Fibril Formation and Genipin Crosslinking as a Potential Injectable Hydrogel by Shunji Yunoki, Yoshimi Ohyabu, Hirosuke Hatayama

    Published 2013-01-01
    “…The temperature-responsive gelation of PSC/genipin solutions was due to temperature responses to genipin crosslinking and collagen fibril formation. The elastic modulus of the 0.5% PSC/genipin gel system could be adjusted in a range of 2.5 to 50 kPa by the PSC and genipin concentrations, suggesting that a PSC/genipin solution is a potential injectable gel system for drug and cell carriers, with mechanical properties matching those of living tissues.…”
    Get full text
    Article
  16. 76

    Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF) by Raffaele De Caterina, Kurt Huber, Richard Schilling, Miklos Rohla, Thomas W Weiss, Ladislav Pecen, Giuseppe Patti, Jolanta M Siller-Matula, Renate B Schnabel, Dipak Kotecha, Markus Lucerna, Paulus Kirchhof

    Published 2019-03-01
    “…Objectives We identified factors associated with thromboembolic and bleeding events in two contemporary cohorts of anticoagulated patients with atrial fibrillation (AF), treated with either vitamin K antagonists (VKA) or non-VKA oral anticoagulants (NOACs).Design Prospective, multicentre observational study.Setting 461 centres in seven European countries.Participants 5310 patients receiving a VKA (PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF), derivation cohort) and 3156 patients receiving a NOAC (PREFER in AF Prolongation, validation cohort) for stroke prevention in AF.Outcome measures Risk factors for thromboembolic events (ischaemic stroke, systemic embolism) and major bleeding (gastrointestinal bleeding, intracerebral haemorrhage and other life-threatening bleeding).Results The mean age of patients enrolled in the PREFER in AF registry was 72±10 years, 40% were female and the mean CHA2DS2-VASc Score was 3.5±1.7. …”
    Get full text
    Article
  17. 77
  18. 78

    Attributable Costs of Postoperative Atrial Fibrillation among Patients Undergoing Cardiac Surgery by Pattamawan Kosuma, Sitichok Wachirasrisirikul, Arom Jedsadayanmata

    Published 2018-01-01
    “…Postoperative atrial fibrillation (POAF) is the most common complication among patients undergoing cardiac surgery. …”
    Get full text
    Article
  19. 79
  20. 80

    A knowledge embedded multimodal pseudo-siamese model for atrial fibrillation detection by Chenglin Lin, Huimin Lu, Pengcheng Sang, Chenyu Pan

    Published 2025-01-01
    “…Abstract Atrial fibrillation (AF) is a common arrhythmia disease with a higher incidence rate. …”
    Get full text
    Article